Menu
Recruiting NCT07293702

IASTM Effects on Pain, Functionality, and Proprioception in Subacromial Impingement

No phase Interventional Subacromial Impingement Syndrome Massage Instrument-Assisted Soft Tissue Mobilization Soft Tissue Injuries

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Conventional exercise group, IASTM group.
Who it may be relevant to
Registry conditions: Subacromial Impingement Syndrome, Massage, Instrument-Assisted Soft Tissue Mobilization, Soft Tissue Injuries. Basic parameters: 40 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

**Effect of Instrument-Assisted Soft Tissue Mobilization on Pain, Functionality, and Proprioception in Individuals With Subacromial Impingement Syndrome**

Overview

The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).

Detailed description

The aim of this study will be to investigate the effects of Instrument-Assisted Soft Tissue Mobilization (IASTM), applied in addition to a conventional exercise program, on pain, range of motion, proprioception, functionality, and quality of life in individuals with Subacromial Impingement Syndrome (SIS).

A total of 38 participants will be included in the study and will be randomly assigned to either the Conventional Exercise Group or the IASTM Group. Both groups will receive treatment for 4 weeks, three sessions per week, for a total of 12 sessions.

Before the intervention, both groups will be assessed for pain (VAS), range of motion (goniometer), joint position sense (goniometer), functionality (Disabilities of the Arm, Shoulder and Hand - DASH), and quality of life (Rotator Cuff Quality of Life - RC-QoL).

Interventions

  • Other Conventional exercise group
    All participants will receive a standardized electrotherapy program in a clinical setting, consisting of TENS (100 Hz, 30 minutes), ultrasound (1.5 W/cm², 8 minutes), and a 15-minute cold-pack application, delivered three times per week for four weeks. In addition to electrotherapy, participants in the conventional exercise group will perform a physiotherapist-guided exercise program aimed at improving shoulder flexion, abduction, internal and external rotation through stretching and range-of-mo
  • Other IASTM group
    Participants in the IASTM group will receive Instrument-Assisted Soft Tissue Mobilization in addition to the conventional treatment program, three days per week for four weeks, for a total of 12 sessions. The IASTM technique will be applied to the subscapularis, anterior deltoid, biceps brachii, upper trapezius, supraspinatus, infraspinatus, teres major, teres minor, and posterior deltoid muscles. For each muscle group, the treatment will be administered for 20 seconds in a parallel direction a

Primary outcome measures

  • Visual Analog Scale [Time frame: From enrollment to the end of treatment at 4 weeks]
  • Range of motion [Time frame: From enrollment to the end of treatment at 4 weeks]
  • The Disabilities of the Arm, Shoulder and Hand (DASH) [Time frame: From enrollment to the end of treatment at 4 weeks]
Secondary outcome measures (2)
  • Joint position sense [Time frame: From enrollment to the end of treatment at 4 weeks]
  • Rotator cuff quality of life Index [Time frame: From enrollment to the end of treatment at 4 weeks]

Eligibility criteria

Inclusion criteria

  • Individuals diagnosed with SIS by MRI
  • Men and women between 40 and 60 years of age
  • Individuals with symptoms persisting for at least one month
  • Individuals with a minimum of 60° of shoulder flexion and abduction range of motion

Exclusion criteria

  • Individuals with a history of surgery on the affected arm
  • Individuals with an open wound on the arm
  • Individuals with an active infection
  • Individuals with inflammatory joint disease
  • Individuals with malignant or benign tumors were excluded from the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Turkey (Türkiye) · 1 center
  • Istanbul Medipol University — Istanbul

Identifiers

NCT: NCT07293702 · E-10840098-202.3.02-6969

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗